India, June 22 -- Bengaluru and San Jose-based data analytics company Tredence has acquired US-based KMK Consulting as it looks to expand its healthcare and life sciences business amid growing adoption of AI across the pharmaceutical sector.

The financial terms of the transaction were not disclosed.

The acquisition comes as Tredence bets heavily on healthcare and life sciences becoming its next major growth engine. The company expects the vertical to account for around 25% of its overall revenue by 2028.

Speaking to Inc42, Tredence cofounding and chief revenue officer Shashank Dubey said the deal is driven by the rapid AI-led transformation underway in the pharmaceutical industry. "The industry spends roughly $250 Bn annually on R&D an...